Black Friday: 20% off all orders with code BLACK20.

Peptide Vials

Tesamorelin Vial

$210.00

Tesamorelin 10 mL Vial

The Science, Simplified: Tesamorelin is a synthetic 44-amino acid analog of growth hormone-releasing hormone (GHRH) featuring an N-terminal trans-3-hexenoyl modification that enhances enzymatic stability in research models.

Product Specifications – Tesamorelin 10 mL Vial (30 mg)

  • Total Tesamorelin: 30 mg
  • Volume: 10 mL vial
  • Concentration: 3 mg/mL
  • Purity: Research-grade, third-party tested (COA available)
  • Format: Ready-to-use liquid vial

Key Research Focus: Studied in laboratory GH-axis systems examining stabilized GHRH receptor agonism and related metabolic signaling pathways under RUO conditions.

Physical Form & Solubility:

  • Appearance: Clear to slightly opalescent liquid
  • Solubility: Already in aqueous solution (acetate salt form for optimal solubility and stability). Highly soluble; no reconstitution required.

Stability & Handling Notes:

  • Refrigerated at 36-46°F. Practical shelf life is 16-20 weeks when protected from light and handled with aseptic technique.
  • Do not freeze. Avoid prolonged room-temperature exposure.
  • Discard after 20 weeks or if the solution becomes cloudy, discolored, or shows particulate matter.
  • Protect from light and moisture at all times.
  • For lyophilized orders please contact us (minimum order required)
    https://www.palmbeach-vitality.com

Tesamorelin 30 mg / 10 mL (3 mg/mL) research vial from Palm Beach Vitality. Third-party tested with COA. Laboratory research use only.

How Labs Use This Format: Pipette at 3 mg/mL from this ready-to-use liquid vial for single-compound Tesamorelin pathway work. The Tesamorelin/Ipamorelin blend vial is available when dual GHRH/GHRP formats are preferred.

Documentation Trail: Third-party testing and lot-matched COA from Palm Beach Vitality support laboratory procurement records. Cold-pack shipping on qualifying orders.

Tesamorelin Research Studies

Selected English-language peer-reviewed references for laboratory research context. Links open publisher or PubMed/PMC records.

Read the Tesamorelin research overview

  1. Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: a randomized controlled trialPubMed 23015655
  2. Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy menPubMed 20943777
  3. The effects of tesamorelin on phosphocreatine recovery in obese subjects with reduced GHPubMed 24178787
  4. Relationship of adiponectin to endogenous GH pulse secretion parameters in response to stimulation with a growth hormone releasing factorPubMed 21531600
  5. Non-clinical pharmacology and safety evaluation of TH9507, a human growth hormone-releasing factor analoguePubMed 17214611
Tesamorelin amino acid chain
Tesamorelin — amino acid chain (N→C)